140 related articles for article (PubMed ID: 10336477)
1. C5a receptor activation. Genetic identification of critical residues in four transmembrane helices.
Baranski TJ; Herzmark P; Lichtarge O; Gerber BO; Trueheart J; Meng EC; Iiri T; Sheikh SP; Bourne HR
J Biol Chem; 1999 May; 274(22):15757-65. PubMed ID: 10336477
[TBL] [Abstract][Full Text] [Related]
2. Genetic mapping of the human C5a receptor. Identification of transmembrane amino acids critical for receptor function.
Geva A; Lassere TB; Lichtarge O; Pollitt SK; Baranski TJ
J Biol Chem; 2000 Nov; 275(45):35393-401. PubMed ID: 10952985
[TBL] [Abstract][Full Text] [Related]
3. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
[TBL] [Abstract][Full Text] [Related]
4. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.
Chen Z; Zhang X; Gonnella NC; Pellas TC; Boyar WC; Ni F
J Biol Chem; 1998 Apr; 273(17):10411-9. PubMed ID: 9553099
[TBL] [Abstract][Full Text] [Related]
5. A novel computational method for predicting the transmembrane structure of G-protein coupled receptors: application to human C5aR and C3aR.
Rayan A; Siew N; Cherno-Schwartz S; Matzner Y; Bautsch W; Goldblum A
Recept Channels; 2000; 7(2):121-37. PubMed ID: 10952089
[TBL] [Abstract][Full Text] [Related]
6. C5a receptor oligomerization. I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor.
Klco JM; Lassere TB; Baranski TJ
J Biol Chem; 2003 Sep; 278(37):35345-53. PubMed ID: 12835319
[TBL] [Abstract][Full Text] [Related]
7. Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor.
Buck E; Wells JA
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2719-24. PubMed ID: 15710877
[TBL] [Abstract][Full Text] [Related]
8. An activation switch in the ligand binding pocket of the C5a receptor.
Gerber BO; Meng EC; Dotsch V; Baranski TJ; Bourne HR
J Biol Chem; 2001 Feb; 276(5):3394-400. PubMed ID: 11062244
[TBL] [Abstract][Full Text] [Related]
9. Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells.
Christophe T; Rabiet MJ; Tardif M; Milcent MD; Boulay F
J Biol Chem; 2000 Jan; 275(3):1656-64. PubMed ID: 10636859
[TBL] [Abstract][Full Text] [Related]
10. C5a receptor antagonists.
Pellas TC; Wennogle LP
Curr Pharm Des; 1999 Oct; 5(10):737-55. PubMed ID: 10526086
[TBL] [Abstract][Full Text] [Related]
11. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W
Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive structure-function map of the intracellular surface of the human C5a receptor. I. Identification of critical residues.
Matsumoto ML; Narzinski K; Kiser PD; Nikiforovich GV; Baranski TJ
J Biol Chem; 2007 Feb; 282(5):3105-21. PubMed ID: 17135254
[TBL] [Abstract][Full Text] [Related]
13. Structural mechanisms of constitutive activation in the C5a receptors with mutations in the extracellular loops: molecular modeling study.
Nikiforovich GV; Baranski TJ
Proteins; 2012 Jan; 80(1):71-80. PubMed ID: 21960464
[TBL] [Abstract][Full Text] [Related]
14. Probing the "message:address" sites for chemoattractant binding to the C5a receptor. Mutagenesis of hydrophilic and proline residues within the transmembrane segments.
Kolakowski LF; Lu B; Gerard C; Gerard NP
J Biol Chem; 1995 Jul; 270(30):18077-82. PubMed ID: 7629117
[TBL] [Abstract][Full Text] [Related]
15. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
Monk PN; Barker MD; Partridge LJ; Pease JE
J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471
[TBL] [Abstract][Full Text] [Related]
16. Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking.
Hagemann IS; Narzinski KD; Floyd DH; Baranski TJ
J Biol Chem; 2006 Dec; 281(48):36783-92. PubMed ID: 17023413
[TBL] [Abstract][Full Text] [Related]
17. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of the first and third extracellular loops of the C5a receptor reveals an essential WXFG motif in the first loop.
Klco JM; Nikiforovich GV; Baranski TJ
J Biol Chem; 2006 Apr; 281(17):12010-9. PubMed ID: 16505476
[TBL] [Abstract][Full Text] [Related]
19. Similar structures and shared switch mechanisms of the beta2-adrenoceptor and the parathyroid hormone receptor. Zn(II) bridges between helices III and VI block activation.
Sheikh SP; Vilardarga JP; Baranski TJ; Lichtarge O; Iiri T; Meng EC; Nissenson RA; Bourne HR
J Biol Chem; 1999 Jun; 274(24):17033-41. PubMed ID: 10358054
[TBL] [Abstract][Full Text] [Related]
20. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
Tardif M; Brouchon L; Rabiet MJ; Boulay F
Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]